SAKAR HEALTHCARE
Back to Balance Sheet
|
SAKAR HEALTHCARE Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹67 Cr | ₹108 Cr | ₹94 Cr | ₹46 Cr | ₹20 Cr |
What is the latest Total Non-Current Liabilities ratio of SAKAR HEALTHCARE ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2024 | ₹67 Cr |
| Mar2023 | ₹108 Cr |
| Mar2022 | ₹94 Cr |
| Mar2021 | ₹46 Cr |
| Mar2020 | ₹20 Cr |
How is Total Non-Current Liabilities of SAKAR HEALTHCARE Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2024 | ₹67 Cr | -38.00 | |
| Mar2023 | ₹108 Cr | 15.99 | |
| Mar2022 | ₹94 Cr | 103.03 | |
| Mar2021 | ₹46 Cr | 135.46 | |
| Mar2020 | ₹20 Cr | - | |
Compare Total Non-Current Liabilities of peers of SAKAR HEALTHCARE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SAKAR HEALTHCARE | ₹812.0 Cr | 3.6% | 0.9% | 20.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,147.0 Cr | -1.4% | 3.6% | -7.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹180,488.0 Cr | 4.4% | 15.9% | 15.6% | Stock Analytics | |
| CIPLA | ₹121,452.0 Cr | -4.9% | -0.8% | 6.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹121,057.0 Cr | -0.6% | 1.8% | 15.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,220.0 Cr | -4.1% | -3.8% | -4.3% | Stock Analytics | |
SAKAR HEALTHCARE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SAKAR HEALTHCARE | 3.6% |
0.9% |
20.9% |
| SENSEX | -1.4% |
3.1% |
3.8% |
You may also like the below Video Courses